Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
160 participants
OBSERVATIONAL
2010-06-30
2017-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators now suspect that the organic changes occurring in the bladder are not the whole story. For one group of patients with pathological urge there is growing evidence suggesting that there may be a strong psychological component. The idea now being put forward is that normal afferent peripheral information is perceived as abnormal and excessive, resulting in an increased desire to go to the bathroom: 'perceptual urge'. It is important to identify this group of patients since it will direct their treatment towards more cognitive approaches. Also, if such a psychological aetiology can be eliminated it would lead to a more focused and effective management of peripheral pathology with surgery or pharmacology.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non-Micturation Bladder Activity in Relation to Self-Consciousness During Filling Phase and Sensation Measurement During the Filling Phase
NCT00628615
The Effect of Position on Urge Sensation in Volunteers and in Patients With Overactive Bladder Syndrome
NCT00821314
Brain Areas Involved in Bladder Filling and Contraction
NCT02477241
Clinical and Urodynamic Assessment of Bladder Sensation in Multiple Sclerosis
NCT05772637
Ambulatory Urodynamic Evaluation of Sacral Neuromodulation for Non-Obstructive Urinary Retention
NCT00970242
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
OAB
Patients with overactive bladder syndrome
Micturition diary
On the micturition diary patients are asked to note every void and drink. With every void they are asked to estimate their bladder volume and grade their degree of desire to void.
Hospital Anxiety and Depression scale
This questionnaire is designed to screen for the presence of a mood disorder.
EuroQol-5D
This questionnaire grades the health condition of the subject.
Self-consciousness questionnaire
The questions tap cognitive, emotional, and physical appearance aspects of directing their attention to the self.
Osteoporosis
Patients with osteoporosis
Micturition diary
On the micturition diary patients are asked to note every void and drink. With every void they are asked to estimate their bladder volume and grade their degree of desire to void.
Hospital Anxiety and Depression scale
This questionnaire is designed to screen for the presence of a mood disorder.
EuroQol-5D
This questionnaire grades the health condition of the subject.
Self-consciousness questionnaire
The questions tap cognitive, emotional, and physical appearance aspects of directing their attention to the self.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Micturition diary
On the micturition diary patients are asked to note every void and drink. With every void they are asked to estimate their bladder volume and grade their degree of desire to void.
Hospital Anxiety and Depression scale
This questionnaire is designed to screen for the presence of a mood disorder.
EuroQol-5D
This questionnaire grades the health condition of the subject.
Self-consciousness questionnaire
The questions tap cognitive, emotional, and physical appearance aspects of directing their attention to the self.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Patients should have at least one episode of urge: sudden compelling desire to void which can not be postponed.
* Well versed in Dutch.
* Patients older than 18 years with osteoporosis joined into the Fast Guide cohort program.
* Well versed in Dutch.
Exclusion Criteria
* Presence of post void residual urine \> 100cc determined by ultrasound
* Presence of urinary tract infection, determined by urine sticks. Patients with urinary tract infection will be treated by antibiotics. After resolution of the infection, the patient can re-enter the study if the urine is sterile at that moment.
* Urinary complaints or urologic history
* Presence of postvoid residual urine \> 100cc determined by ultrasound
* Presence of urinary tract infection, determined by urine sticks. Patients that present with urinary tract infection will be definitively excluded from participation.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Maastricht University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gommert van Koeveringe, MD, PhD, urologist
Role: STUDY_DIRECTOR
Maastricht University Medical Centre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maastricht University Medical Centre
Maastricht, Limburg, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
09-1234567
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.